Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trialMasatoshi Kudo, Yasuaki Arai, Namiki Izumi et al.|Gut|2019Cited by 720
<i><scp>EVI</scp>1</i>, a target gene for amplification at 3q26, antagonizes transforming growth factor‐β‐mediated growth inhibition in hepatocellular carcinomaKohichiroh Yasui, Yoshito Itoh|Cancer Science|2015Cited by 22
Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomachTomohiro Soda, Kohichiroh Yasui|Scientific Reports|2022Cited by 6